Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2009. Start Trial.
Date Value
January 31, 2023 -25.01M
October 31, 2022 -28.64M
July 31, 2022 -32.38M
April 30, 2022 -33.92M
January 31, 2022 -41.88M
October 31, 2021 -42.72M
July 31, 2021 -42.59M
April 30, 2021 -43.50M
January 31, 2021 -38.41M
October 31, 2020 -34.75M
July 31, 2020 -33.15M
April 30, 2020 -31.88M
January 31, 2020 -31.36M
October 31, 2019 -30.37M
July 31, 2019 -29.01M
April 30, 2019 -27.16M
January 31, 2019 -25.29M
October 31, 2018 -24.99M
July 31, 2018 -23.29M
April 30, 2018 -21.69M
January 31, 2018 -20.34M
October 31, 2017 -18.01M
July 31, 2017 -17.36M
April 30, 2017 -17.18M
January 31, 2017 -17.54M
Date Value
October 31, 2016 -18.66M
July 31, 2016 -19.36M
April 30, 2016 -20.79M
January 31, 2016 -21.23M
October 31, 2015 -20.36M
July 31, 2015 -19.08M
April 30, 2015 -16.26M
January 31, 2015 -13.54M
October 31, 2014 -11.29M
July 31, 2014 -9.493M
April 30, 2014 -7.821M
January 31, 2014 -6.937M
October 31, 2013 -6.497M
July 31, 2013 -5.648M
April 30, 2013 -5.677M
January 31, 2013 -4.969M
October 31, 2012 -4.542M
July 31, 2012 -4.274M
April 30, 2012 -4.181M
January 31, 2012 -3.506M
October 31, 2011 -2.564M
July 31, 2011 -1.620M
April 30, 2011 -0.2894M
January 31, 2011 -0.021M
October 31, 2010 -0.0115M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 145.62M
Alnylam Pharmaceuticals, Inc. 793.94M
Savara, Inc. -110.66M
Vericel Corp. 61.66M
Biogen, Inc. 2.49B